Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06372288 · ClinicalTrials.gov registry record · NA
Theta Burst TMS for Treatment of Methamphetamine Use Disorder
A NA study of Methamphetamine Abuse, sponsored by Carilion Clinic.
- Recruiting
- Registry status
- NA
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT06372288: Recruiting NA study of Methamphetamine Abuse, sponsored by Carilion Clinic.
NCT06372288 is a NA study of Methamphetamine Abuse that is actively recruiting participants, run by Carilion Clinic. The registered enrollment target is 40 participants, below the 206-participant average among 15 other Methamphetamine Abuse trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06372288, a NA study of Methamphetamine Abuse, is actively recruiting participants, sponsored by Carilion Clinic.
- RECRUITING
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is using Transcranial Magnetic Stimulation (TMS) to determine if interventional psychiatry treatment can help with the treatment of Methamphetamine Use Disorder. Individuals with Methamphetamine Use Disorder will receive 5 consecutive TMS treatment sessions based off of randomization. Participants will be randomized to one of two groups. TMS treatment arm or sham-TMS arm.
Conditions Studied
Interventions
- DEVICE Transcranial Magnetic Stimulation
- DEVICE Sham Transcranial Magnetic Stimulation
Study Locations (1)
Virginia
- Carilion Clinic - Roanoke
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2023-12-20 |
| Est. Completion | 2025-12 |
| Phase | NA |
What NCT06372288 shows while recruiting
NCT06372288 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 206-participant average among 15 other Methamphetamine Abuse trials with a reported enrollment target (81% lower).
The record links to 1 condition, with Methamphetamine Abuse appearing as the primary indexed condition, and to 2 interventions - of which Transcranial Magnetic Stimulation is the first listed.
NCT06372288 reports a single indexed study location in Virginia.
Frequently Asked Questions
What is clinical trial NCT06372288 about?
NCT06372288 is a clinical study titled "Theta Burst TMS for Treatment of Methamphetamine Use Disorder". This study is using Transcranial Magnetic Stimulation (TMS) to determine if interventional psychiatry treatment can help with the treatment of Methamphetamine Use Disorder. Individuals with Methamphetamine Use Disorder will receive 5 consecutive TMS treatment sessions based off of randomization. Par...
What is the current status of trial NCT06372288?
This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2023-12-20. Estimated completion is 2025-12.
What conditions does trial NCT06372288 study?
This clinical trial studies the following conditions: Methamphetamine Abuse.
What interventions are being tested in trial NCT06372288?
The interventions under investigation include: Transcranial Magnetic Stimulation (DEVICE), Sham Transcranial Magnetic Stimulation (DEVICE).
Who is sponsoring clinical trial NCT06372288?
This trial is sponsored by Carilion Clinic, which has 45 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06372288 being conducted?
This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Methamphetamine Abuse
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06372288's enrollment target sits among peer trials
40 11th of 15 higher than 4 of 15 other Methamphetamine Abuse trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Methamphetamine Abuse trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Encouraging Abstinence Behavior in a Drug Epidemic: Optimizing Dynamic Incentives
RECRUITING · NA
-
rTMS for Craving in Methamphetamine Use Disorder
RECRUITING · NA
-
Mood and Decision-making in Methamphetamine Use Disorder
RECRUITING · NA
-
Contingency Management for Drug Use: Does Age Matter?
ACTIVE NOT RECRUITING · NA
-
Peer Engagement in Methamphetamine Harm-Reduction With Contingency Management (PEER-CM)
ACTIVE NOT RECRUITING · NA
-
Demonstration of a Digital Care Program for Methamphetamine Use Disorder
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI